Home › Companies › ACHV
Q2Q3Q4Q1 ’27Q2Q3Q4Q1 ’28
- Cytisinicline smoking cessation NDA filing4Q 2026Cytisinicline smoking cessation NDA filing, 4Q 2026, major
- Cytisinicline smoking cessation corporate update4Q 2026Cytisinicline smoking cessation corporate update, 4Q 2026, material
- Cytisinicline smoking cessation FDA approval1H 2027Cytisinicline smoking cessation FDA approval, 1H 2027, thesis-defining
- Cytisinicline vaping cessation Ph3 startOct 2027Cytisinicline vaping cessation Ph3 start, Oct 2027, routine
- Cytisinicline vaping cessation corporate updateOct 2027Cytisinicline vaping cessation corporate update, Oct 2027, routine
Bar width shows how precise the guidance is — a pin is a stated date, a wide band a
six-month window. Deeper blue means more of the thesis rides on the event; it is not a
view on the stock.
Pipeline (2 active programs)
Biotech Distilled coverage (2)
Articles open on Substack. Some deep dives are subscriber-only.